Literature DB >> 2230153

Comparison of an enzyme-linked immunosorbent assay (ELISA) with a radioimmunoassay (RIA) for the measurement of rat insulin.

H V Webster1, A J Bone, K A Webster, T J Wilkin.   

Abstract

A recently developed competitive enzyme-linked immunosorbent assay (ELISA) was compared with a conventional competitive radioimmunoassay (RIA) for the measurement of rat insulin in culture medium. Fifty-six samples were analysed by both assays. There was a correlation coefficient of r = 0.783 between results obtained using the two assay systems. The binding curves of the two assays were differently shaped, so that the ELISA gave good reproducibility over the concentration range 5-50 microU/ml insulin with inter- and intra-assay coefficients of variation less than 14%, but poor reproducibility at higher concentrations. Conversely, the RIA showed excellent reproducibility at concentrations greater than 50 microU/ml insulin, but poor sensitivity and high coefficients of variation below this level. The ELISA procedure offers practical advantages over the RIA, and performs well when measuring physiological concentrations of insulin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2230153     DOI: 10.1016/0022-1759(90)90116-d

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  Insulin targeting to the regulated secretory pathway after fusion with green fluorescent protein and firefly luciferase.

Authors:  A E Pouli; H J Kennedy; J G Schofield; G A Rutter
Journal:  Biochem J       Date:  1998-04-15       Impact factor: 3.857

2.  Chemoprotective effects of butanol fraction of Buchholzia coriacea (Capparidaceae) against type 2 diabetes and oxidative stress in male Wistar rats.

Authors:  Amanda C Okolie; Oluwafemi E Kale; Odutola Osilesi
Journal:  Biosci Rep       Date:  2019-02-15       Impact factor: 3.840

Review 3.  Stepping forward in antibody-drug conjugate development.

Authors:  Yiming Jin; Megan A Schladetsch; Xueting Huang; Marcy J Balunas; Andrew J Wiemer
Journal:  Pharmacol Ther       Date:  2021-06-24       Impact factor: 12.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.